Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
InSilico Medicine Cayman TopCo (3696)
Market Closed
12 Aug, 08:00
HKEX
All
(2)
HK
(1)
US
(1)
HKEX
Primary
OTC PINK
45.
92
HKD
-2.08
-4.3333%
HKD
23.03B
Market Cap
-
P/E Ratio
-
Div Yield
10.2M
Volume
-
Eps
48
HKD
Previous Close
Watching
Watch
Add Transaction
Day Range
45.68
48.76
Year Range
29.98
80.9
Want to track
3696
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Statistics
Historical Data
InSilico Medicine Cayman TopCo (3696) Statistics
Valuation metrics
Market Cap
23.03B
Enterprise value
169.47B
Trailing P/E (ttm)
-9.09
Forward P/E
-513.49
PEG ratio
-513.49
Price/Sales (ttm)
409.56
Price/Book (mrq)
6.33
Enterprise Value/Revenue
384.45
Enterprise Value/EBITDA
-377.43
Overview
Shares outstanding
557.42M
Float
438.83M
Shares short
-
% Held by insiders
0.33%
% Held by institutions
0.53%
Average volume (10 days)
4.2M
Average volume (90 days)
3.65M
Price summary
52-Week low
29.98
52-Week high
80.9
Beta
-
50-Day moving average
58.24
200-Day moving average
58.72
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.82%
Operating margin
-1.31%
Operational effectiveness
Return on assets
-0.12%
Return on equity
-0.78%
Income Statement
Revenue (ttm)
440.8M
Revenue per share (ttm)
0.71
Quarterly revenue growth (yoy)
0.1%
Gross profit (ttm)
359.35M
EBITDA
-448.99M
Net income to common (ttm)
-2.76B
Diluted EPS (ttm)
-35.11
Quarterly earnings growth (yoy)
-
Balance Sheet
Total cash (mrq)
3.51B
Total cash per share (mrq)
0.8
Total debt (mrq)
46.71M
Total Debt/Equity (mrq)
1.32
Current ratio (mrq)
13.99%
Book value per share (mrq)
6.36
Cash Flow
Cash flow statement
-601.68M
Levered free cash flow (LFCF)
-6.43B